By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Practice > Clinical Updates > Trump’s Perfect Cognitive Test Score: What Montreal Cognitive Assessment Really Measures
Clinical UpdatesExplainersPerspectivesPractice

Trump’s Perfect Cognitive Test Score: What Montreal Cognitive Assessment Really Measures

GMJ
Last updated: 15/06/2026 20:30
By
GMJ Practice Desk
Share
6 Min Read
Medical professional administering cognitive assessment test showing Montreal Cognitive Assessment scoring sheetIllustrative image · Photo by Andy Barbour on Pexels (Pexels License)
President Trump's perfect 30/30 score on cognitive testing prompts medical experts to clarify what the Montreal Cognitive Assessment actually measures. The screening tool detects cognitive decline, not intelligence levels. — Photo by Andy Barbour on Pexels (Pexels License)
SHARE
🎧 Listen to this article3:26 min · 476 words · GMJ Audio
2 min read|476 words
✓ Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD · ORCID 0000-0001-7609-4515

🟠 Moderate Evidence

Contents
    • Key takeaways
  • What the White House Medical Report Shows
  • Trump’s Claims About the Test Results
  • What The BMJ Analysis Reveals
    • What this means
  • Frequently asked questions
    • What did Trump’s doctor report about his cognitive test?
    • What did Trump claim about his test results?
    • When did Trump take this cognitive assessment?

President Donald Trump’s recent claims about achieving “extreme intelligence” on cognitive testing have sparked medical debate about what these assessments actually measure. According to The BMJ analysis of his 26 May physical examination, Trump scored 30/30 on the Montreal Cognitive Assessment (MoCA).

Key takeaways

  • Trump scored a perfect 30/30 on the Montreal Cognitive Assessment during his routine physical examination
  • White House physician Sean P. Barbabella reported Trump’s cognitive performance “fell within normal ranges”
  • Trump claimed on Truth Social that his perfect score demonstrated “extreme intelligence”
30/30
Trump’s perfect score on Montreal Cognitive Assessment, as reported by White House physician Sean P. Barbabella

What the White House Medical Report Shows

White House physician Sean P. Barbabella published his report on Trump’s cardiac, pulmonary, neurological, and overall physical function on 30 May. As part of the neurological component, Trump’s cognition was assessed using the Montreal Cognitive Assessment.

“Trump’s cognitive performance, measured by the Montreal Cognitive Assessment, fell within normal ranges, achieving a perfect score of 30/30,” Barbabella recorded in his medical report.

Submit Your Paper
GMJ_Submit_Banner
🎙️ Related Podcast Episodes
🎧 #43 | GMJ Podcast | Cardiovascular Screening in Pediatric Athletes — Risk Stratification and Public Health Implications · 20m
🎧 #25 | WHO Warns: Childhood Hearing Loss Must Be Addressed Early · 19m
🎧 #24 | WHO Releases Updated Health Inequality Data Repository and Equity Toolkit · 21m
🎧 #13 | Six Years After COVID-19: Is the World Better Prepared for the Next Pandemic? · 19m

Trump’s Claims About the Test Results

In a post on Truth Social, Trump wrote: “Unlike other U.S. Presidents, none of whom have ever taken an approved, high difficulty, Cognitive Test, I scored a perfect 30 out of 30, considered ‘extreme intelligence.'”

According to The BMJ’s analysis, Trump described the cognitive tests as “high difficulty” and claimed they demonstrated “extreme intelligence.”

What The BMJ Analysis Reveals

The BMJ examined what Trump’s test results actually indicate. The Montreal Cognitive Assessment is a cognitive screening tool, and according to The BMJ’s fact-check, the assessment evaluates basic cognitive functions rather than measuring intelligence levels.

Presidential cognitive assessments have become increasingly scrutinized, with routine physical examinations for older leaders typically including neurological screening.

What this means

For patients: Cognitive screening tools assess normal brain function and are designed to detect potential cognitive decline
For clinicians: The Montreal Cognitive Assessment serves as a screening instrument for cognitive function evaluation
For policymakers: Presidential health assessments continue to be subject of public scrutiny and medical interpretation

Frequently asked questions

What did Trump’s doctor report about his cognitive test?

White House physician Sean P. Barbabella reported that Trump achieved a perfect score of 30/30 on the Montreal Cognitive Assessment, with performance falling “within normal ranges.”

What did Trump claim about his test results?

Trump posted on Truth Social that he scored “a perfect 30 out of 30” on what he called a “high difficulty, Cognitive Test,” claiming this was “considered ‘extreme intelligence.'”

When did Trump take this cognitive assessment?

The cognitive assessment was part of Trump’s routine physical examination conducted on 26 May, with results published by the White House on 30 May.

As The BMJ’s fact-check demonstrates, there remains significant discussion about the interpretation and public communication of cognitive assessment results in political contexts.

Source: Trump fact check: Did the president’s health check show “extreme intelligence”?

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

Finerenone Shows Cardiovascular Benefits in Non-Diabetic Chronic Kidney Disease PatientsJun 15, 2026
Breakthrough Drug Targeting 'Undruggable' KRAS Mutation Nearly Doubles Pancreatic Cancer SurvivalJun 15, 2026
Prenatal Zika exposure linked to vision, hearing deficits despite apparently healthy birthsJun 15, 2026
FDA Issues Recall Alert for Contaminated Saline Nasal Spray Sold on AmazonJun 15, 2026
PG
Written by
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
Get the GMJ News digest
Evidence-based health journalism in your inbox. No spam; unsubscribe anytime.
TAGGED:cognitive assessmentMoCA testMontreal Cognitive Assessmentneurological screeningpresidential health
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByGMJ Practice Desk
Follow:
GMJ Practice Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Finerenone Shows Cardiovascular Benefits in Non-Diabetic Chronic Kidney Disease Patients

Finerenone significantly reduces cardiovascular events by 14% in non-diabetic chronic kidney disease…

Pediatric influenza hospitalizations nearly doubled post-pandemic, Canadian surveillance finds

Canadian surveillance study reveals pediatric influenza hospitalizations nearly doubled in 2022–2023, with…

Breakthrough Drug Targeting ‘Undruggable’ KRAS Mutation Nearly Doubles Pancreatic Cancer Survival

New targeted therapy daraxonrasib successfully inhibits KRAS mutations in pancreatic cancer, nearly…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

PET scan image showing blood clot detection in legs and lungs using novel radiotracer technology"Advances in stroke treatment" is licensed under CC BY 4.0. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. (CC BY 4.0)
Clinical UpdatesNew StudiesPracticeResearch Digest

Novel PET Tracer Detects Blood Clots in Legs and Lungs with Single Scan

By
GMJ Practice Desk
13/06/2026
Children using digital mental health platform showing emotional well-being improvement graphs
Clinical UpdatesPractice

Digital Platform Significantly Reduces Distress Among Children of Divorce

By
GMJ Practice Desk
24/05/2026
Clinical laboratory showing advanced cell and gene therapy preparation in a controlled environment
Clinical Updates

New guidance on advanced therapy clinical trials: What researchers need to know

By
GMJ Practice Desk
20/05/2026
Medical illustration showing immune system intervention preventing rheumatoid arthritis development
Clinical UpdatesNew StudiesPracticeResearch Digest

Immune Drug Delays Rheumatoid Arthritis by Four Years After Treatment Ends

By
GMJ Practice Desk
03/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up